These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1352125)

  • 1. Expression of c-erbB-2 protein in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Br J Cancer; 1992 Jun; 65(6):832-7. PubMed ID: 1352125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of heregulins and associations with the ErbB family of tyrosine kinase receptors in papillary thyroid carcinomas.
    Fluge O; Akslen LA; Haugen DR; Varhaug JE; Lillehaug JR
    Int J Cancer; 2000 Sep; 87(6):763-70. PubMed ID: 10956383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-erbB-2 oncoprotein in human thyroid tumours.
    Utrilla JC; Martín-Lacave I; San Martín MV; Fernández-Santos JM; Galera-Davidson H
    Histopathology; 1999 Jan; 34(1):60-5. PubMed ID: 9934586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic staining of erbB-2 but not mRNA levels correlates with differentiation in human thyroid neoplasia.
    Sugg SL; Ezzat S; Zheng L; Rosen IB; Freeman JL; Asa SL
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):629-37. PubMed ID: 10197079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.
    Bièche I; Ruffet E; Zweibaum A; Vildé F; Lidereau R; Franc B
    Thyroid; 1997 Oct; 7(5):725-31. PubMed ID: 9349575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met expression of thyroid tissue with special reference to papillary carcinoma.
    Oyama T; Ichimura E; Sano T; Kashiwabara K; Fukuda T; Nakajima T
    Pathol Int; 1998 Oct; 48(10):763-8. PubMed ID: 9788259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Cancer Res; 1996 Mar; 56(6):1184-8. PubMed ID: 8640794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
    Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
    J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical and in situ hybridization study of c-myc and c-erbB-2 expression in primary human breast carcinomas.
    Walker RA; Senior PV; Jones JL; Critchley DR; Varley JM
    J Pathol; 1989 Jun; 158(2):97-105. PubMed ID: 2569035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
    J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.
    Saito T; Endo T; Kawaguchi A; Ikeda M; Katoh R; Kawaoi A; Muramatsu A; Onaya T
    J Clin Invest; 1998 Apr; 101(7):1296-300. PubMed ID: 9525971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of motilin and its precursor mRNA in normal parenchyma, benign and malignant tumors of human thyroid].
    Xu L; Zhong F; Guo FF; Zhao WJ; Sun XR; Wei XF
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):243-9. PubMed ID: 18844033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene profile of papillary thyroid carcinoma.
    Sugg SL; Ezzat S; Zheng L; Freeman JL; Rosen IB; Asa SL
    Surgery; 1999 Jan; 125(1):46-52. PubMed ID: 9889797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
    Branet F; Caron P; Camallières M; Selves J; Brousset P
    Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-filament expression in thyroid gland carcinomas.
    Schröder S; Dockhorn-Dworniczak B; Kastendieck H; Böcker W; Franke WW
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):751-66. PubMed ID: 3094239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics.
    Irani S; Salajegheh A; Gopalan V; Smith RA; Lam AK
    Ann Diagn Pathol; 2014 Apr; 18(2):43-8. PubMed ID: 24332749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
    Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
    Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.